Rosen Law Firm reminds purchasers of Embecta Corp. common stock between November 25, 2025 and May 4, 2026 of the August 17, 2026 lead plaintiff deadline in a securities class action. The lawsuit alleges that Embecta made false or misleading statements and concealed adverse facts about its fiscal results, including touting its pen needle business as "incredibly resolute" weeks before missing expectations and cutting 2026 guidance. Investors who purchased shares during the class period may be entitled to compensation through a contingency fee arrangement. To join the class action or seek lead plaintiff status, investors must contact the firm before the deadline.
Embecta CorpSecurities class action alleges false statements and concealed adverse facts, creating legal and financial risk.